Turnstone Biologics Corporation (TSBX) Sof foyda bo'yicha sotuv rentabelligi

Turnstone Biologics Corp (TSBX) tovar belgisi

Turnstone Biologics qattiq o'smalarga qarshi kurashish uchun inqilobiy onkolitik vaksinalarni ishlab chiqmoqda va RSU tizimi orqali yetakchi virologlarni jalb qilmoqda. Operatsion sof foyda marjasi xarajatlar samaradorligini namoyish etadi, bunda 0.00 ushbu ko'rsatkichning joriy qiymatini belgilaydi. Immunoterapiya ekspertlari jamoasi taqdim etilgan ilmiy avtonomiya va aksiyalarda ishtirok etishni qadrlagan holda, ilg'or viral platformalarga tayanadi.

TSBX: turnstonebio.com Kompaniyaning sof rentabelligi 21.02.2024 - 24.08.2025

Turnstone Biologics kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:Turnstone Biologics Corporation - TSBX
turnstonebio.com yetakchi tovari

Sotuv marjasi har bir topilgan dollarning sof foydadagi ulushini o'lchaydi va tijorat operatsiyalarining fundamental samaradorligini belgilaydi. Turnstone Biologics (TSBX) uchun ushbu parametr hozirgi vaqtda sotuvlar mavjud emasligi sababli shakllanish bosqichida. Sotuv marjasi qiymatini tahlil qilish orqali investor kelgusidagi daromadlilik potentsialini aniqlashi mumkin. Qattiq o'simtalar terapiyasi usullari uchun patent himoyasi kompaniyaga sezilarli narx belgilash imkoniyatini beradi. Ushbu ko'rsatkich klinik sinovlar yakunlangach, aktivlar sifatining asosiy o'lchoviga aylanadi.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi ZYME (Zymeworks Corp)|Kompaniyaning sof rentabelligi TNGX|Sotuvning sof marjinal rentabelligi IOVA (Iovance Biotherapeutics, Inc.)|Sof foyda normasi IMTX|xencor.com - Sotuvning sof marjinal rentabelligi|Sof marja Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Sof marja|Lyell Immunopharma - Sof foyda normasi|IPHA (innate-pharma.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi pyxisoncology.com|Sof marja cgen.com (CGEN)|IOBT: Sof foyda marjasi|Sutro Biopharma Inc. - Sof foyda bo'yicha sotuv rentabelligi|minktherapeutics.com (INKT) - Sof marja|HOWL: Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi Immix Biopharma IMMX|ALX Oncology (ALXO) - Sof marja|Sof marja Cue Biopharma, Inc. (CUE)|Sof marja PDS Biotechnology Corporation|Sotuvning sof rentabelligi SONN (sonnetbio.com)|Sotuvning sof marjinal rentabelligi MAIA|Kompaniya sotuv marjasi Liminatus Pharma Inc.|LAVA Therapeutics N.V. - Sof foyda bo'yicha sotuv rentabelligi|NXTC - Sof foyda bo'yicha sotuv rentabelligi|LPTX: Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi intensitytherapeutics.com INTS|SNSE (Sensei Bio) - Sof foyda bo'yicha sotuv rentabelligi|Synthetic Biologics (TOVX) - Sotuvning sof marjinal rentabelligi|Sof marja Gritstone bio|Sof foyda bo'yicha sotuv rentabelligi Kineta, Inc. (KA)|Sotuvning sof marjinal rentabelligi NEXI|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)